Novo Nordisk
Expert Collections containing Novo Nordisk
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Novo Nordisk is included in 3 Expert Collections, including Diabetes.
Diabetes
1,750 items
Medical Devices
3,088 items
Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)
Digital Health
410 items
Companies developing and enabling evidence-based, software-driven therapeutic interventions to prevent, manage, or treat a medical disorder or disease. (*Scope follows the Digital Therapeutics Alliance definition)
Novo Nordisk Patents
Novo Nordisk has filed 101 patents.
The 3 most popular patent topics include:
- Drug delivery devices
- Diabetes
- Medical equipment
Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
7/15/2020 | 5/24/2022 | Graphical projections, Technical drawing, Roadsters, Light machine guns, Cephalopod zootomy | Grant |
Application Date | 7/15/2020 |
---|---|
Grant Date | 5/24/2022 |
Title | |
Related Topics | Graphical projections, Technical drawing, Roadsters, Light machine guns, Cephalopod zootomy |
Status | Grant |
Latest Novo Nordisk News
May 27, 2022
The race to meet sudden, stratospheric demand for new anti-obesity meds is hotting up, but Novo Nordisk (NOV: N) CEO Lars Fruergaard Jørgensen takes a collegiate approach. According to analysts, the global market for obesity treatments is set to be worth $27 billion by 2028, growing annually at a blistering average of 17%. Such swollen forecasts are in no small part the result of R&D investments made by Novo Nordisk, which leads the way in… This article is accessible to registered users, to continue reading please register for free . A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login . If your trial has come to an end, you can subscribe here. • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech. • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results. • Daily roundup of key events in pharma and biotech. • Monthly in-depth briefings on Boardroom appointments and M&A news. • Choose from a cost-effective annual package or a flexible monthly subscription. If you are already a registered user please login . The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed Chairman, Sanofi Aventis UK
Novo Nordisk Web Traffic
Novo Nordisk Rank
Where is Novo Nordisk's headquarters?
Novo Nordisk's headquarters is located at Brucknerstrasse 1, Mainz.
Who are Novo Nordisk's competitors?
Competitors of Novo Nordisk include Merck KGaA.
You May Also Like
Lilly is a pharmaceutical company. The company focuses on diabetes, cancer, immunology, pain, and neurodegeneration drugs. It is based in Toronto, Ontario.

Novartis (NYSE: NVS) is a global healthcare company that provides solutions to address the evolving needs of patients worldwide. Focusing solely on healthcare, Novartis offers a diversified portfolio to meet these needs including medicines, cost-saving generic pharmaceuticals, preventive vaccines, diagnostic tools, and consumer health products.

Sanofi (Euronext: SAN) (NYSE: SNY) engages in the research, production, and distribution of pharmaceutical products in the prescription market, as well as over-the-counter medication. The company covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines.
Takeda Pharmaceutical (TYO: 4502) (NYSE: TAK) is a research-based, global pharmaceutical company.

Johnson & Johnson (NYSE: JNJ) is a multi-national manufacturer of pharmaceutical, diagnostic, therapeutic, surgical, and biotechnology products, as well as personal hygiene products.
Merck Group (FWB: MRK), aka Merck KGaA, is a science and technology company in the healthcare, life science, and performance materials businesses. The company develops biopharmaceutical therapies to treat cancer or multiple sclerosis, systems for scientific research and production, liquid crystals for smartphones and LCD televisions and more. Its former subsidiary Merck & Co. (NYSE: MRK) is a separate independent company.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.